Vanda Pharmaceuticals | VNDA - Eigenkapital Und Reserven

Aktienkurs
7.22
Täglich Wechseln
-0.11 -1.50%
Monatlich
-22.28%
Jährlich
74.82%
Q2 Prognose
7.02




Eigenkapital Und Reserven Veränderung Datum
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Agios Pharmaceuticals USD 1.19B 91.22M 2025-12
Akebia Therapeutics USD 32.61M 8.98M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Anika Therapeutics USD 143.46M 3.34M 2025-12
Arrowhead Research USD 568.42M 102.37M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Eli Lilly USD 26.54B 2.74B 2025-12
Enanta Pharmaceuticals USD 126.59M 61.87M 2025-12
Esperion Therapeutics USD -301.96M 149.4M 2025-12
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
Heron Therapeutics USD 13.28M 1.6M 2025-12
Insmed USD 738.98M 206.6M 2025-12
J&J USD 78.47B 0 2025-09
Lexicon Pharmaceuticals USD 107.54M 12.62M 2025-12
Ligand Pharmaceuticals USD 1.02B 67.04M 2025-12
Merck USD 51.85B 2.79B 2025-09
Minerva Neurosciences USD -140.75M 106.17M 2025-12
Moderna USD 8.65B 680M 2025-12
Novartis USD 46.13B 1.8B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
PTC Therapeutics USD -205.31M 49.56M 2025-12
Puma Biotechnology USD 115.27M 10.55M 2025-09
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sanofi EUR 71.71B 1.55B 2025-12
Takeda JPY 7.64T 513.39B 2025-12
Teva Pharmaceutical Industries USD 7.91B 664M 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12
Veracyte USD 1.26B 36.61M 2025-09